3 \03\Europe/Madrid April \03\Europe/Madrid 2024
The use of CBD products poses no risk, nor any significant adverse effects or side effects for our pets. These products are non-psychoactive and do not induce addiction in the animal. Conventional veterinary medications negatively impact the immune and digestive...
27 \27\Europe/Madrid March \27\Europe/Madrid 2024
How do you see the UK market for both medicinal and recreational cannabis? Medical cannabis is the best kept secret in UK healthcare. We’re a nation of some 67 million people, but a patient population of less than 40,000. Given that there’s around 1.8 million...
29 \29\Europe/Madrid February \29\Europe/Madrid 2024
What are the main challenges to implementing genetics within the medicinal use of cannabis? In our quest for knowledge and solutions, we encounter a fascinating and complex subject: the challenges in implementing cannabis genetics in medicinal use. This field,...
26 \26\Europe/Madrid February \26\Europe/Madrid 2024
Epilepsy is one of the most common neurological disorders, affecting around 70 million people worldwide. 65% of patients are managed with antiepileptic drugs and lead a normal life but, what about the remaining 35%? These patients suffer from refractory epilepsy,...
31 \31\Europe/Madrid January \31\Europe/Madrid 2024
What benefits do you think the implementation of the regulation of medical cannabis in Spain could bring? The nationwide commercial regulation of cannabis provides many benefits that are distinct from merely allowing businesses to exist, like the present status quo in...
24 \24\Europe/Madrid January \24\Europe/Madrid 2024
The fungal composition of the phytobiome of C. sativa, known as the mycobiome, currently consists of more than 100 species of fungi. The most common ones are Aspergillus, Penicillium, Fusarium, and Mucor spp. The interactions of the mycobiome with cannabis and hemp...
